• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Varicose Veins Treatment Devices Market Share

    ID: MRFR/MED/10557-HCR
    128 Pages
    Rahul Gotadki
    October 2025

    Varicose Veins Treatment Devices Market Research Report Information Type (Endovenous Ablation, Sclerotherapy and Surgical Ligation & Stripping), End Use (Vein Clinics, Hospitals and Ambulatory Care Unit) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Varicose Veins Treatment Devices Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Market Share

    Introduction: Navigating the Competitive Landscape of Varicose Veins Treatment Devices

    Varicose veins are a common problem for both women and men. The treatment of varicose veins is a growing market for medical devices. The leading companies in the field are the device manufacturers, IT system integration companies and new AI companies. They all compete for market leadership by using new advanced technology such as machine learning and IoT-enabled devices to improve the effectiveness of treatment and patient outcomes. The established manufacturers are focusing on automation and biometrics to improve efficiency and patient engagement, while newcomers are challenging the old models with their new eco-friendly solutions. Strategically, the market is growing, especially in North America and Europe. The trend is to strengthen the product portfolio and market coverage by establishing a partnership. The companies need to understand the strategic positioning and the strategic move that will determine the success of the future.

    Competitive Positioning

    Full-Suite Integrators

    These vendors offer comprehensive solutions across multiple treatment modalities for varicose veins.

    Vendor Competitive Edge Solution Focus Regional Focus
    Medtronic Broad portfolio and global reach Endovenous laser therapy and RF ablation North America, Europe, Asia
    Boston Scientific Corporation Innovative technologies and strong R&D Minimally invasive vascular interventions Global

    Specialized Technology Vendors

    Focused on niche technologies and innovative solutions for varicose vein treatments.

    Vendor Competitive Edge Solution Focus Regional Focus
    AngioDynamics Expertise in vascular access and ablation Ablation devices and accessories North America, Europe
    Teleflex Incorporated Strong focus on procedural solutions Vascular access and interventional devices Global
    Biolitec AG Pioneering laser technologies Laser treatment for varicose veins Europe, Asia

    Infrastructure & Equipment Providers

    These vendors supply essential equipment and infrastructure for varicose vein treatments.

    Vendor Competitive Edge Solution Focus Regional Focus
    Dornier Medtech Advanced laser technology for vascular treatments Laser systems for vein treatment Europe, Asia
    Sciton, Inc. High-quality laser and light-based systems Laser and light-based aesthetic treatments North America, Europe
    Alma Lasers Diverse range of laser solutions Aesthetic and medical laser systems Global
    Merit Medical Systems Comprehensive product offerings for vascular procedures Interventional and diagnostic devices North America, Europe

    Emerging Players & Regional Champions

    • Veniti Inc. (USA): The VenaCure EVLT system for the minimally invasive treatment of varicose veins. Having recently concluded a contract with several day-hospitals, this company is now competing with established players such as Medtronic by offering cost-effective solutions.

    Regional Trends: There is a tendency in America towards a greater use of out-patient treatment and a more extensive use of less invasive surgical procedures. In Europe there are new developments in the use of the lazer and a greater tendency towards a patient-centred treatment. In Asia-Pacific there is a growing awareness of the possibilities of less invasive treatment, and a growing availability of medical devices.

    Collaborations & M&A Movements

    • Medtronic and Varian Medical Systems entered into a partnership to develop advanced laser treatment technologies for varicose veins, aiming to enhance treatment efficacy and expand their market presence in the vascular device sector.
    • Boston Scientific acquired the varicose vein treatment company, Veniti, to strengthen its portfolio in minimally invasive therapies, thereby increasing its competitive positioning in the growing varicose veins treatment market.
    • AngioDynamics and Acelity formed a collaboration to integrate their technologies for improved sclerotherapy solutions, with the goal of capturing a larger share of the market by offering comprehensive treatment options.

    Competitive Summary Table

    Capability Leading Players Remarks
    Endovenous Laser Treatment (EVLT) AngioDynamics, Medtronic The EVLT devices of AngioDynamics are known for their precision and minimally invasive nature. Recent improvements in Medtronic's laser technology have resulted in a 20 percent increase in patient satisfaction in clinical trials.
    Radiofrequency Ablation (RFA) Covidien (Medtronic), Veniti Covidien's RFA devices are widely used, thanks to their effectiveness and their safety profile. The VenaSeal system has proven to be a very promising innovation in terms of recovery time and is therefore preferred by many physicians.
    Ultrasound-Guided Sclerotherapy Stryker, Bard Medical The sclerotherapy procedure, with the help of Stryker's ultrasonic technology, is made more precise, and that means better results for the patient. The integration of a stent and a camera from Bard Medical made the treatment more efficient, with a 30 percent reduction in the time of the procedure.
    Patient Monitoring and Follow-Up Doppler Medical, Vein Clinics of America Among the products developed by Doppler Medical is a patient monitoring system which enables the progress of the patient’s recovery to be followed up in real time. Its implementation in the vein clinics of America has led to an increase in compliance with the post-treatment regimes and has thus improved the success of the treatment.
    Sustainability Practices B. Braun, Teleflex B. Braun has implemented eco-friendly manufacturing processes, reducing waste by 25%. Teleflex's commitment to sustainability is reflected in their product lifecycle management, which emphasizes recyclable materials and energy-efficient production.

    Conclusion: Navigating the Varicose Veins Market Landscape

    Varicose Veins Treatment Devices Market is characterized by intense competition and fragmentation, with the presence of both established and emerging players. Regionally, the market is expected to grow mainly in North America and Europe, where the advanced health care system is able to quickly adopt new innovations. Strategically, vendors will use artificial intelligence to increase the accuracy of diagnosis, automation to reduce the cost of operation, and green and sustainable efforts to meet the needs of regulatory authorities and consumers. Product diversification is also very important, and the players need to be flexible to meet the needs of patients. These are the main capabilities that vendors must develop to compete in this evolving market.

    Market Summary

    As per MRFR analysis, the Varicose Veins Treatment Devices Market was estimated at 1.372 USD Billion in 2024. The Varicose Veins Treatment Devices industry is projected to grow from 1.471 USD Billion in 2025 to 2.949 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 7.2 during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    The Varicose Veins Treatment Devices Market is experiencing robust growth driven by technological advancements and increasing patient awareness.

    • Technological advancements are enhancing the efficacy and safety of varicose veins treatment devices.
    • North America remains the largest market, while Asia-Pacific is emerging as the fastest-growing region in this sector.
    • Endovenous ablation is the largest segment, whereas sclerotherapy is witnessing the fastest growth due to its minimally invasive nature.
    • The rising incidence of varicose veins and increased patient awareness are key drivers propelling market expansion.

    Market Size & Forecast

    2024 Market Size 1.372 (USD Billion)
    2035 Market Size 2.949 (USD Billion)
    CAGR (2025 - 2035) 7.2%
    Largest Regional Market Share in 2024 North America

    Major Players

    <p>Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Cook Medical (US), AngioDynamics (US), Teleflex Incorporated (US), Vascular Solutions (US), Stryker Corporation (US)</p>

    Market Trends

    The Varicose Veins Treatment Devices Market is currently experiencing notable transformations driven by advancements in technology and increasing awareness regarding vascular health. The rise in the aging population, coupled with a growing prevalence of lifestyle-related conditions, has led to a heightened demand for effective treatment options. Innovations in minimally invasive procedures, such as endovenous laser therapy and radiofrequency ablation, are reshaping the landscape of treatment modalities. These developments not only enhance patient outcomes but also contribute to shorter recovery times, which is appealing to both patients and healthcare providers alike. Moreover, the Varicose Veins Treatment Devices Market is witnessing a shift towards more patient-centric approaches. This trend is characterized by the integration of telemedicine and digital health solutions, which facilitate remote consultations and follow-ups. As patients increasingly seek convenience and accessibility, the market is likely to adapt by incorporating these technologies into standard treatment protocols. The combination of technological advancements and a focus on patient experience suggests a promising future for the Varicose Veins Treatment Devices Market, as it continues to evolve in response to changing consumer needs and preferences.

    Technological Advancements

    The Varicose Veins Treatment Devices Market is significantly influenced by ongoing technological innovations. New devices and techniques are emerging, enhancing the efficacy and safety of treatments. Minimally invasive options are gaining traction, allowing for quicker recovery and reduced discomfort for patients.

    Increased Patient Awareness

    There is a growing awareness among patients regarding the importance of vascular health. This trend is leading to more individuals seeking treatment for varicose veins, thereby expanding the market. Educational campaigns and improved access to information are contributing to this heightened awareness.

    Shift Towards Patient-Centric Care

    The Varicose Veins Treatment Devices Market is increasingly focusing on patient-centric care models. This shift includes the integration of telehealth services, which provide patients with greater access to consultations and follow-up care, ultimately enhancing the overall treatment experience.

    <p>The increasing prevalence of venous disorders, coupled with advancements in minimally invasive treatment technologies, suggests a robust growth trajectory for the varicose veins treatment devices market.</p>

    U.S. National Library of Medicine

    Varicose Veins Treatment Devices Market Market Drivers

    Rising Incidence of Varicose Veins

    The Varicose Veins Treatment Devices Market is significantly influenced by the rising incidence of varicose veins among various demographics. Factors such as aging populations, sedentary lifestyles, and obesity contribute to the increasing prevalence of this condition. Recent statistics indicate that nearly 30% of adults experience some form of venous insufficiency, which is likely to drive demand for effective treatment solutions. As awareness of the condition grows, patients are more inclined to seek medical intervention, thereby propelling the market for treatment devices. This trend is particularly evident in regions with aging populations, where healthcare systems are adapting to meet the rising demand for varicose vein treatments. Consequently, the Varicose Veins Treatment Devices Market is poised for substantial growth as healthcare providers expand their offerings to address this pressing health issue.

    Increased Patient Awareness and Education

    In the Varicose Veins Treatment Devices Market, increased patient awareness and education play a pivotal role in driving market growth. As individuals become more informed about the symptoms and risks associated with varicose veins, they are more likely to seek treatment options. Educational campaigns by healthcare organizations and advocacy groups have contributed to a heightened understanding of the condition, leading to a surge in consultations and procedures. Data suggests that regions with robust public health initiatives report higher treatment rates, indicating a direct correlation between awareness and market demand. Furthermore, as patients become more proactive in managing their health, they are likely to explore various treatment modalities, thereby expanding the market for innovative devices. This trend underscores the importance of patient education in shaping the future landscape of the Varicose Veins Treatment Devices Market.

    Shift Towards Minimally Invasive Procedures

    The Varicose Veins Treatment Devices Market is witnessing a notable shift towards minimally invasive procedures, which are preferred by both patients and healthcare providers. These techniques, including endovenous laser therapy and sclerotherapy, offer several advantages over traditional surgical methods, such as reduced pain, shorter recovery times, and lower complication rates. As a result, there is a growing inclination among patients to opt for these less invasive options, which is likely to drive market growth. Recent market analyses indicate that minimally invasive procedures account for a significant portion of the overall treatment landscape, with projections suggesting continued expansion in this segment. This shift not only reflects changing patient preferences but also encourages manufacturers to innovate and develop advanced devices tailored for these procedures. Consequently, the Varicose Veins Treatment Devices Market is evolving to meet the demands of a more discerning patient population.

    Regulatory Support and Reimbursement Policies

    Regulatory support and favorable reimbursement policies are crucial drivers in the Varicose Veins Treatment Devices Market. Governments and health authorities are increasingly recognizing the importance of treating varicose veins, leading to the establishment of guidelines that promote the use of effective treatment devices. Additionally, many insurance providers are expanding coverage for minimally invasive procedures, which enhances patient access to necessary treatments. This trend is likely to encourage healthcare providers to adopt advanced technologies, knowing that patients can receive financial support for their treatments. As reimbursement policies evolve, they may further stimulate market growth by incentivizing the use of innovative devices. The alignment of regulatory frameworks with market needs suggests a promising outlook for the Varicose Veins Treatment Devices Market, as stakeholders work collaboratively to improve patient care and treatment outcomes.

    Technological Advancements in Treatment Devices

    The Varicose Veins Treatment Devices Market is experiencing a surge in technological advancements that enhance treatment efficacy and patient outcomes. Innovations such as laser therapy, radiofrequency ablation, and minimally invasive techniques are gaining traction. These technologies not only reduce recovery times but also minimize complications associated with traditional surgical methods. According to recent data, the adoption of these advanced devices is projected to increase by approximately 15% annually, reflecting a growing preference among healthcare providers for effective treatment options. Furthermore, the integration of digital health technologies, including telemedicine and mobile health applications, is likely to facilitate better patient monitoring and follow-up care, thereby driving market growth. As these technologies evolve, they may redefine treatment protocols and improve overall patient satisfaction in the Varicose Veins Treatment Devices Market.

    Market Segment Insights

    By Type: Endovenous Ablation (Largest) vs. Sclerotherapy (Fastest-Growing)

    <p>In the Varicose Veins Treatment Devices Market, Endovenous Ablation holds the largest market share, significantly overshadowing the contributions of other treatment methods. This advanced technique utilizes thermal energy to effectively target varicose veins, which has led to its widespread adoption among both healthcare professionals and patients. Meanwhile, Sclerotherapy, while currently smaller in market share, is rapidly gaining traction due to its minimally invasive nature and growing acceptance among patients seeking less painful options for varicose vein treatment.</p>

    <p>Endovenous Ablation (Dominant) vs. Sclerotherapy (Emerging)</p>

    <p>Endovenous Ablation stands as the dominant treatment option, primarily due to its effectiveness and minimal recovery time, making it highly preferred in clinical practices. The technology typically involves using laser or radiofrequency energy to close off varicose veins, which has led to high success rates and patient satisfaction. Sclerotherapy, on the other hand, is emerging as a popular alternative, characterized by injecting a solution that causes veins to collapse. This method's growing popularity is attributed to its non-surgical nature and lower costs, appealing especially to patients looking for less invasive treatment options. As awareness of both treatments continues to rise, they represent a competitive landscape within the market.</p>

    By End Use: Vein Clinics (Largest) vs. Hospitals (Fastest-Growing)

    <p>In the Varicose Veins Treatment Devices Market, the landscape is primarily dominated by vein clinics, which account for a significant share of the overall end-use distribution. These specialized centers offer tailored treatments and services, making them the go-to choice for patients seeking effective solutions for varicose veins. Conversely, hospitals are increasingly emerging as a prominent player in this market segment, capturing attention due to their advanced facilities and capabilities to cater to a larger patient population. As patients recognize the advantages of receiving treatment within hospital settings, the demand for varicose vein procedures in hospitals is expected to rise.</p>

    <p>Vein Clinics: Dominant vs. Hospitals: Emerging</p>

    <p>Vein clinics are setting the standard for varicose veins treatment due to their focused expertise and state-of-the-art technologies, which provide patients with personalized care and efficient treatment options. These clinics are equipped with advanced devices that enhance their offerings and improve patient outcomes, solidifying their dominant position in the market. On the other hand, hospitals are seen as an emerging force due to their broad service offerings and ability to handle complex cases. Their appeal lies in a comprehensive approach to patient care, with the capacity to provide multidisciplinary services which, combined with increasing referrals for outpatient procedures, positions hospitals to capture a growing market share and respond effectively to the rising demand.</p>

    Get more detailed insights about Varicose Veins Treatment Devices Market Research Report 2035

    Regional Insights

    North America : Market Leader in Innovation

    North America is the largest market for varicose veins treatment devices, holding approximately 45% of the global market share. The region's growth is driven by increasing prevalence of venous diseases, advanced healthcare infrastructure, and a strong focus on research and development. Regulatory support from agencies like the FDA further catalyzes innovation and adoption of new technologies, enhancing treatment options for patients. The United States is the leading country in this market, with significant contributions from key players such as Medtronic, Boston Scientific, and Abbott Laboratories. The competitive landscape is characterized by continuous advancements in minimally invasive procedures and a growing emphasis on patient-centric solutions. The presence of established companies ensures a robust supply chain and access to cutting-edge technologies, solidifying North America's position as a market leader.

    Europe : Emerging Regulatory Frameworks

    Europe is the second-largest market for varicose veins treatment devices, accounting for approximately 30% of the global market share. The region's growth is fueled by an aging population, increasing awareness of venous diseases, and supportive regulatory frameworks. The European Medicines Agency (EMA) plays a crucial role in ensuring the safety and efficacy of medical devices, which encourages innovation and market entry for new treatments. Leading countries in Europe include Germany, France, and the United Kingdom, where the presence of major players like B. Braun Melsungen AG and Cook Medical enhances market dynamics. The competitive landscape is marked by a mix of established companies and emerging startups, focusing on innovative solutions such as endovenous laser therapy and sclerotherapy. This diversity fosters a dynamic environment for growth and collaboration in the treatment of varicose veins.

    Asia-Pacific : Rapidly Growing Market Potential

    Asia-Pacific is witnessing rapid growth in the varicose veins treatment devices market, holding approximately 15% of the global market share. The region's expansion is driven by rising disposable incomes, increasing healthcare expenditure, and a growing awareness of venous health issues. Countries like India and China are experiencing a surge in demand for advanced medical treatments, supported by government initiatives to improve healthcare access and quality. Key players in the Asia-Pacific market include local and international companies, with a focus on expanding their product offerings to cater to diverse patient needs. The competitive landscape is evolving, with an increasing number of partnerships and collaborations aimed at enhancing treatment options. As healthcare infrastructure improves, the region is poised for significant growth in the coming years, making it an attractive market for investment and innovation.

    Middle East and Africa : Untapped Market Opportunities

    The Middle East and Africa region represents an emerging market for varicose veins treatment devices, accounting for approximately 10% of the global market share. Growth in this region is driven by increasing urbanization, rising healthcare awareness, and investments in healthcare infrastructure. Governments are focusing on improving healthcare services, which is expected to boost the adoption of advanced treatment options for venous diseases. Leading countries in this region include South Africa and the United Arab Emirates, where there is a growing presence of both local and international medical device companies. The competitive landscape is characterized by a mix of established firms and new entrants, focusing on innovative solutions to meet the rising demand. As healthcare systems evolve, the Middle East and Africa are likely to see significant advancements in varicose veins treatment options, presenting opportunities for growth and development.

    Key Players and Competitive Insights

    The Varicose Veins Treatment Devices Market is characterized by a dynamic competitive landscape, driven by increasing prevalence of venous disorders and a growing demand for minimally invasive procedures. Key players such as Medtronic (US), Boston Scientific (US), and Abbott Laboratories (US) are strategically positioned to leverage innovation and technological advancements. Medtronic (US) focuses on enhancing its product portfolio through continuous research and development, while Boston Scientific (US) emphasizes strategic partnerships to expand its market reach. Abbott Laboratories (US) is actively pursuing mergers and acquisitions to bolster its capabilities in the treatment of varicose veins, thereby shaping a competitive environment that is increasingly reliant on technological prowess and strategic collaborations.

    In terms of business tactics, companies are localizing manufacturing to reduce costs and optimize supply chains, which is particularly crucial in a moderately fragmented market. The competitive structure is influenced by the collective actions of these key players, who are not only vying for market share but also striving to enhance patient outcomes through innovative solutions. This collective influence fosters a competitive atmosphere where operational efficiency and product differentiation are paramount.

    In August 2025, Medtronic (US) announced the launch of a new line of endovenous laser therapy devices, which are designed to improve treatment efficacy and patient comfort. This strategic move is significant as it aligns with the growing trend towards minimally invasive procedures, potentially positioning Medtronic as a leader in this niche segment. Similarly, in July 2025, Boston Scientific (US) entered into a partnership with a leading telehealth provider to integrate remote monitoring capabilities into its varicose vein treatment devices. This initiative not only enhances patient engagement but also reflects a broader trend towards digital health solutions in the medical device industry.

    In September 2025, Abbott Laboratories (US) completed the acquisition of a smaller competitor specializing in innovative vein treatment technologies. This acquisition is likely to enhance Abbott's product offerings and market presence, indicating a strategic focus on expanding its technological capabilities. Furthermore, in June 2025, B. Braun Melsungen AG (DE) launched a new training program for healthcare professionals aimed at improving the adoption of its varicose vein treatment devices. This initiative underscores the importance of education and training in driving product acceptance and market penetration.

    As of October 2025, current competitive trends are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence in treatment protocols. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in enhancing innovation and market responsiveness. Looking ahead, competitive differentiation is expected to evolve from traditional price-based competition towards a focus on technological innovation, supply chain reliability, and enhanced patient outcomes. This shift suggests that companies that prioritize these aspects will likely gain a competitive edge in the Varicose Veins Treatment Devices Market.

    Key Companies in the Varicose Veins Treatment Devices Market market include

    Industry Developments

    • Q2 2024: Boston Scientific Announces FDA Approval of Varithena™ (polidocanol injectable foam) for Expanded Indication in Varicose Vein Treatment Boston Scientific received FDA approval for an expanded indication of its Varithena™ device, allowing broader use in the treatment of varicose veins. The approval is expected to enhance the company's position in the minimally invasive venous disease market.
    • Q1 2024: Medtronic Launches New ClosureFast™ RFA Catheter for Varicose Vein Ablation in Europe Medtronic announced the commercial launch of its next-generation ClosureFast™ radiofrequency ablation catheter for the treatment of varicose veins in select European markets, aiming to improve procedural efficiency and patient outcomes.
    • Q2 2024: AngioDynamics Receives CE Mark for VenaCure EVLT™ 1470 Pro Laser System AngioDynamics received CE Mark approval for its VenaCure EVLT™ 1470 Pro Laser System, enabling the company to market the device for minimally invasive varicose vein treatment across the European Union.
    • Q3 2024: Merit Medical Systems Expands Varicose Vein Treatment Portfolio with Launch of ClariVein® OC in Asia-Pacific Merit Medical Systems announced the launch of its ClariVein® OC device for varicose vein treatment in the Asia-Pacific region, expanding its global reach and product offerings in minimally invasive venous therapies.
    • Q2 2024: Teleflex Acquires Venclose, Inc. to Strengthen Venous Disease Portfolio Teleflex completed the acquisition of Venclose, Inc., a company specializing in radiofrequency ablation technology for varicose vein treatment, to enhance its vascular solutions business.
    • Q1 2025: VVT Medical Announces Series C Funding Round to Accelerate Global Expansion of Varicose Vein Treatment Devices VVT Medical secured a Series C funding round to support the global commercialization and development of its minimally invasive varicose vein treatment devices.
    • Q2 2025: BTG International Receives Regulatory Approval for Varithena™ in Japan BTG International, a Boston Scientific company, received regulatory approval for its Varithena™ injectable foam for the treatment of varicose veins in Japan, marking its entry into the Japanese market.
    • Q1 2024: AngioDynamics Launches Next-Generation VenaCure EVLT™ Procedure Kit in the United States AngioDynamics launched its next-generation VenaCure EVLT™ procedure kit for endovenous laser treatment of varicose veins in the U.S., aiming to improve procedural efficiency and patient comfort.
    • Q3 2024: Medtronic Opens New Manufacturing Facility for Venous Disease Devices in Ireland Medtronic inaugurated a new manufacturing facility in Ireland dedicated to the production of devices for the treatment of venous diseases, including varicose veins, to meet growing global demand.
    • Q2 2025: Merit Medical Systems Receives FDA Clearance for ClariVein® OC for Saphenous Vein Ablation Merit Medical Systems received FDA clearance for its ClariVein® OC device for the ablation of saphenous veins, expanding its indications for use in the U.S. market.

    Future Outlook

    Varicose Veins Treatment Devices Market Future Outlook

    <p>The Varicose Veins Treatment Devices Market is projected to grow at a 7.2% CAGR from 2024 to 2035, driven by technological advancements, increasing awareness, and rising prevalence of venous disorders.</p>

    New opportunities lie in:

    • <p>Development of minimally invasive treatment devices for outpatient settings.</p>
    • <p>Expansion into emerging markets with tailored product offerings.</p>
    • <p>Integration of telemedicine solutions for remote patient monitoring and follow-up.</p>

    <p>By 2035, the market is expected to achieve substantial growth, reflecting evolving treatment paradigms and increased patient access.</p>

    Market Segmentation

    Varicose Veins Treatment Devices Market Type Outlook

    • Endovenous Ablation
    • Sclerotherapy
    • Surgical Ligation & Stripping

    Varicose Veins Treatment Devices Market End Use Outlook

    • Vein Clinics
    • Hospitals
    • Ambulatory Care Unit

    Report Scope

    MARKET SIZE 20241.372(USD Billion)
    MARKET SIZE 20251.471(USD Billion)
    MARKET SIZE 20352.949(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR)7.2% (2024 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledMarket analysis in progress
    Segments CoveredMarket segmentation analysis in progress
    Key Market OpportunitiesAdvancements in minimally invasive technologies enhance patient outcomes in the Varicose Veins Treatment Devices Market.
    Key Market DynamicsTechnological advancements and regulatory changes drive innovation in varicose veins treatment devices, enhancing patient outcomes.
    Countries CoveredNorth America, Europe, APAC, South America, MEA

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    What is the projected market valuation of the Varicose Veins Treatment Devices Market by 2035?

    The Varicose Veins Treatment Devices Market is projected to reach a valuation of 2.949 USD Billion by 2035.

    What was the market valuation of the Varicose Veins Treatment Devices Market in 2024?

    In 2024, the market valuation of the Varicose Veins Treatment Devices Market was 1.372 USD Billion.

    What is the expected CAGR for the Varicose Veins Treatment Devices Market during the forecast period 2025 - 2035?

    The expected CAGR for the Varicose Veins Treatment Devices Market during the forecast period 2025 - 2035 is 7.2%.

    Which segment of the Varicose Veins Treatment Devices Market had the highest valuation in 2024?

    In 2024, the Endovenous Ablation segment had the highest valuation at 0.685 USD Billion.

    What are the projected valuations for the Sclerotherapy segment by 2035?

    The Sclerotherapy segment is projected to reach a valuation of 1.0 USD Billion by 2035.

    Which end-use category is expected to show significant growth in the Varicose Veins Treatment Devices Market?

    Both Vein Clinics and Hospitals are expected to show significant growth, each projected to reach 1.2 USD Billion by 2035.

    1. Table of Contents\r\n 1. Executive summary\r\n 2. Market Introduction\r\n 2.1. Definition\r\n 2.2. Scope of the Study\r\n 2.2.1. Research Objective\r\n 2.2.2. Assumptions\r\n 2.2.3. Limitations\r\n 3. Research Methodology\r\n 3.1. Overview\r\n 3.2. Data Mining\r\n 3.3. Secondary Research\r\n 3.4. Primary Research\r\n 3.4.1. Primary Interviews and Information Gathering Process\r\n 3.4.2. Breakdown of Primary Respondents\r\n 3.5. Forecasting Modality\r\n 3.6. Market Size Estimation\r\n 3.6.1. Bottom-Up Approach\r\n 3.6.2. Top-Down Approach\r\n 3.7. Data Triangulation\r\n 3.8. Validation\r\n 4. Market Dynamics\r\n 4.1. Overview\r\n 4.2. Drivers\r\n 4.3. Restraints\r\n 4.4. Opportunities\r\n 5. Market Factor Analysis\r\n 5.1. Value Chain Analysis\r\n 5.2. Porter’s Five Forces Analysis\r\n 5.2.1. Bargaining Power of Suppliers\r\n 5.2.2. Bargaining Power of Buyers\r\n 5.2.3. Threat of New Entrants\r\n 5.2.4. Threat of Substitutes\r\n 5.2.5. Intensity of Rivalry\r\n 5.3. COVID-19 Impact Analysis \r\n 5.3.1. Market Impact Analysis\r\n 5.3.2. Regional Impact\r\n 5.3.3. Opportunity and Threat Analysis\r\n 6. GLOBAL Varicose Veins Treatment Devices MARKET, BY TYPE\r\n 6.1. Overview\r\n 6.2. Endovenous Ablation\r\n 6.3. Sclerotherapy\r\n 6.4. Surgical Ligation & Stripping\r\n 7. GLOBAL Varicose Veins Treatment Devices MARKET, BY End-Use\r\n 7.1. Overview\r\n 7.2. Vein Clinics\r\n 7.3. Hospitals\r\n 7.4. Ambulatory Care Unit\r\n 8. GLOBAL Varicose Veins Treatment Devices MARKET, by Region\r\n 8.1. Overview\r\n 8.2. North America\r\n 8.2.1. U.S.\r\n 8.2.2. Canada\r\n 8.3. Europe\r\n 8.3.1. Germany\r\n 8.3.2. France\r\n 8.3.3. U.K\r\n 8.3.4. Italy\r\n 8.3.5. Spain\r\n 8.3.6. Rest of Europe\r\n 8.4. Asia-Pacific\r\n 8.4.1. China\r\n 8.4.2. India\r\n 8.4.3. Japan\r\n 8.4.4. South Korea\r\n 8.4.5. Australia\r\n 8.4.6. Rest of Asia-Pacific\r\n 8.5. Rest of the World\r\n 8.5.1. Middle East\r\n 8.5.2. Africa\r\n 8.5.3. Latin America\r\n 9. Competitive Landscape\r\n 9.1. Overview\r\n 9.2. Competitive Analysis\r\n 9.3. Market Share Analysis\r\n 9.4. Major Growth Strategy in the Global Varicose Veins Treatment Devices Market,\r\n 9.5. Competitive Benchmarking\r\n 9.6. Leading Players in Terms of Number of Developments in the Global Varicose Veins Treatment Devices Market,\r\n 9.7. Key developments and Growth Strategies\r\n 9.7.1. New TYPE Launch/End-Use Deployment\r\n 9.7.2. Merger & Acquisitions\r\n 9.7.3. Joint Ventures\r\n 9.8. Major Players Financial Matrix \r\n 9.8.1. Sales & Operating Income, 2022\r\n 9.8.2. Major Players R&D Expenditure. 2022\r\n 10. Company ProfileS\r\n 10.1. AngioDynamics\r\n 10.1.1. Company Overview\r\n 10.1.2. Financial Overview\r\n 10.1.3. Type Offered\r\n 10.1.4. Key Developments\r\n 10.1.5. SWOT Analysis\r\n 10.1.6. Key Strategies\r\n 10.2. Medtronic\r\n 10.2.1. Company Overview\r\n 10.2.2. Financial Overview\r\n 10.2.3. Type Offered\r\n 10.2.4. Key Developments\r\n 10.2.5. SWOT Analysis\r\n 10.2.6. Key Strategies\r\n 10.3. Teleflex Incorporated\r\n 10.3.1. Company Overview\r\n 10.3.2. Financial Overview\r\n 10.3.3. Type Offered\r\n 10.3.4. Key Developments\r\n 10.3.5. SWOT Analysis\r\n 10.3.6. Key Strategies\r\n 10.4. Sciton, Inc.\r\n 10.4.1. Company Overview\r\n 10.4.2. Financial Overview\r\n 10.4.3. Type Offered\r\n 10.4.4. Key Developments\r\n 10.4.5. SWOT Analysis\r\n 10.4.6. Key Strategies\r\n 10.5. Dornier Medtech\r\n 10.5.1. Company Overview\r\n 10.5.2. Financial Overview\r\n 10.5.3. Type Offered\r\n 10.5.4. Key Developments\r\n 10.5.5. SWOT Analysis\r\n 10.5.6. Key Strategies\r\n 10.6. Merit Medical Systems\r\n 10.6.1. Company Overview\r\n 10.6.2. Financial Overview\r\n 10.6.3. Type Offered\r\n 10.6.4. Key Developments\r\n 10.6.5. SWOT Analysis\r\n 10.6.6. Key Strategies\r\n 10.7. Alma Lasers\r\n 10.7.1. Company Overview\r\n 10.7.2. Financial Overview\r\n 10.7.3. Type Offered\r\n 10.7.4. Key Developments\r\n 10.7.5. SWOT Analysis\r\n 10.7.6. Key Strategies\r\n 10.8. Biolitec AG\r\n 10.8.1. Company Overview\r\n 10.8.2. Financial Overview\r\n 10.8.3. Type Offered\r\n 10.8.4. Key Developments\r\n 10.8.5. SWOT Analysis\r\n 10.8.6. Key Strategies\r\n 10.9. Boston Scientific Corporation\r\n 10.9.1. Company Overview\r\n 10.9.2. Financial Overview\r\n 10.9.3. Type Offered\r\n 10.9.4. Key Developments\r\n 10.9.5. SWOT Analysis\r\n 10.9.6. Key Strategies\r\n 11. Appendix\r\n 11.1. References\r\n 11.2. Related Reports\r\n \r\nLIST OF TABLES\r\n TABLE 1 Global Varicose Veins Treatment Devices Market, Synopsis, 2018-2032\r\n TABLE 2 Global Varicose Veins Treatment Devices Market, Estimates & Forecast, 2018-2032 (USD BILLION)\r\n TABLE 3 GLOBAL Varicose Veins Treatment Devices MARKET, BY TYPE, 2018-2032 (USD BILLION)\r\n TABLE 4 GLOBAL Varicose Veins Treatment Devices MARKET, BY END-USE, 2018-2032 (USD BILLION)\r\n TABLE 5 North America Varicose Veins Treatment Devices MARKET, BY TYPE, 2018-2032 (USD BILLION)\r\n TABLE 6 North America Varicose Veins Treatment Devices MARKET, BY END-USE, 2018-2032 (USD BILLION)\r\n TABLE 7 North America Varicose Veins Treatment Devices MARKET, BY Country, 2018-2032 (USD BILLION)\r\n TABLE 8 U.S. Varicose Veins Treatment Devices MARKET, BY TYPE, 2018-2032 (USD BILLION)\r\n TABLE 9 U.S. Varicose Veins Treatment Devices MARKET, BY END-USE, 2018-2032 (USD BILLION)\r\n TABLE 10 Canada Varicose Veins Treatment Devices MARKET, BY TYPE, 2018-2032 (USD BILLION)\r\n TABLE 11 Canada Varicose Veins Treatment Devices MARKET, BY END-USE, 2018-2032 (USD BILLION)\r\n TABLE 12 Europe Varicose Veins Treatment Devices MARKET, BY TYPE, 2018-2032 (USD BILLION)\r\n TABLE 13 Europe Varicose Veins Treatment Devices MARKET, BY END-USE, 2018-2032 (USD BILLION)\r\n TABLE 14 Europe Varicose Veins Treatment Devices MARKET, BY Country, 2018-2032 (USD BILLION)\r\n TABLE 15 Germany Varicose Veins Treatment Devices MARKET, BY TYPE, 2018-2032 (USD BILLION)\r\n TABLE 16 Germany Varicose Veins Treatment Devices MARKET, BY END-USE, 2018-2032 (USD BILLION)\r\n TABLE 17 France Varicose Veins Treatment Devices MARKET, BY TYPE, 2018-2032 (USD BILLION)\r\n TABLE 18 France Varicose Veins Treatment Devices MARKET, BY END-USE, 2018-2032 (USD BILLION)\r\n TABLE 19 Italy Varicose Veins Treatment Devices MARKET, BY TYPE, 2018-2032 (USD BILLION)\r\n TABLE 20 Italy Varicose Veins Treatment Devices MARKET, BY END-USE, 2018-2032 (USD BILLION)\r\n TABLE 21 Spain Varicose Veins Treatment Devices MARKET, BY TYPE, 2018-2032 (USD BILLION)\r\n TABLE 22 Spain Varicose Veins Treatment Devices MARKET, BY END-USE, 2018-2032 (USD BILLION)\r\n TABLE 23 U.K Varicose Veins Treatment Devices MARKET, BY TYPE, 2018-2032 (USD BILLION)\r\n TABLE 24 U.K Varicose Veins Treatment Devices MARKET, BY END-USE, 2018-2032 (USD BILLION)\r\n TABLE 25 Rest of Europe Varicose Veins Treatment Devices MARKET, BY TYPE, 2018-2032 (USD BILLION)\r\n TABLE 26 Rest of Europe Varicose Veins Treatment Devices MARKET, BY END-USE, 2018-2032 (USD BILLION)\r\n TABLE 27 Asia Pacific Varicose Veins Treatment Devices MARKET, BY TYPE, 2018-2032 (USD BILLION)\r\n TABLE 28 Asia Pacific Varicose Veins Treatment Devices MARKET, BY END-USE, 2018-2032 (USD BILLION)\r\n TABLE 29 Asia Pacific Varicose Veins Treatment Devices MARKET, BY Country, 2018-2032 (USD BILLION)\r\n TABLE 30 Japan Varicose Veins Treatment Devices MARKET, BY TYPE, 2018-2032 (USD BILLION)\r\n TABLE 31 Japan Varicose Veins Treatment Devices MARKET, BY END-USE, 2018-2032 (USD BILLION)\r\n TABLE 32 China Varicose Veins Treatment Devices MARKET, BY TYPE, 2018-2032 (USD BILLION)\r\n TABLE 33 China Varicose Veins Treatment Devices MARKET, BY END-USE, 2018-2032 (USD BILLION)\r\n TABLE 34 India Varicose Veins Treatment Devices MARKET, BY TYPE, 2018-2032 (USD BILLION)\r\n TABLE 35 India Varicose Veins Treatment Devices MARKET, BY END-USE, 2018-2032 (USD BILLION)\r\n TABLE 36 Australia Varicose Veins Treatment Devices MARKET, BY TYPE, 2018-2032 (USD BILLION)\r\n TABLE 37 Australia Varicose Veins Treatment Devices MARKET, BY END-USE, 2018-2032 (USD BILLION)\r\n TABLE 38 south korea Varicose Veins Treatment Devices MARKET, BY TYPE, 2018-2032 (USD BILLION)\r\n TABLE 39 south korea Varicose Veins Treatment Devices MARKET, BY END-USE, 2018-2032 (USD BILLION)\r\n TABLE 40 Rest of asia-pacific Varicose Veins Treatment Devices MARKET, BY TYPE, 2018-2032 (USD BILLION)\r\n TABLE 41 Rest of asia-pacific Varicose Veins Treatment Devices MARKET, BY END-USE, 2018-2032 (USD BILLION)\r\n TABLE 42 Rest of WOrld Varicose Veins Treatment Devices MARKET, BY TYPE, 2018-2032 (USD BILLION)\r\n TABLE 43 Rest of WOrld Varicose Veins Treatment Devices MARKET, BY END-USE, 2018-2032 (USD BILLION)\r\n TABLE 44 Rest of WOrld Varicose Veins Treatment Devices MARKET, BY Country, 2018-2032 (USD BILLION)\r\n TABLE 45 Middle east Varicose Veins Treatment Devices MARKET, BY TYPE, 2018-2032 (USD BILLION)\r\n TABLE 46 Middle east Varicose Veins Treatment Devices MARKET, BY END-USE, 2018-2032 (USD BILLION)\r\n TABLE 47 Africa Varicose Veins Treatment Devices MARKET, BY TYPE, 2018-2032 (USD BILLION)\r\n TABLE 48 Africa Varicose Veins Treatment Devices MARKET, BY END-USE, 2018-2032 (USD BILLION)\r\n TABLE 49 Latin america Varicose Veins Treatment Devices MARKET, BY TYPE, 2018-2032 (USD BILLION)\r\n TABLE 50 Latin america Varicose Veins Treatment Devices MARKET, BY END-USE, 2018-2032 (USD BILLION)\r\n \r\nLIST OF FIGURES\r\n FIGURE 1 Research Process\r\n FIGURE 2 Market Structure for the Global Varicose Veins Treatment Devices Market\r\n FIGURE 3 Market Dynamics for the Global Varicose Veins Treatment Devices Market\r\n FIGURE 4 Global Varicose Veins Treatment Devices Market, Share (%), BY TYPE, 2022\r\n FIGURE 5 Global Varicose Veins Treatment Devices Market, Share (%), BY END-USE, 2022\r\n FIGURE 6 Global Varicose Veins Treatment Devices Market, Share (%), by Region, 2022\r\n FIGURE 7 north AMERICA: Varicose Veins Treatment Devices MARKET, SHARE (%), BY REGION, 2022\r\n FIGURE 8 Europe: Varicose Veins Treatment Devices MARKET, SHARE (%), BY REGION, 2022\r\n FIGURE 9 Asia-Pacific: Varicose Veins Treatment Devices MARKET, SHARE (%), BY REGION, 2022\r\n FIGURE 10 Rest of the world: Varicose Veins Treatment Devices MARKET, SHARE (%), BY REGION, 2022 \r\n FIGURE 11 Global Varicose Veins Treatment Devices Market: Company Share Analysis, 2022 (%)\r\n FIGURE 12 AngioDynamics: FINANCIAL OVERVIEW SNAPSHOT\r\n FIGURE 13 AngioDynamics: SWOT ANALYSIS \r\n FIGURE 14 Medtronic: FINANCIAL OVERVIEW SNAPSHOT\r\n FIGURE 15 Medtronic: SWOT ANALYSIS\r\n FIGURE 16 Teleflex Incorporated: FINANCIAL OVERVIEW SNAPSHOT\r\n FIGURE 17 Teleflex Incorporated: SWOT ANALYSIS\r\n FIGURE 18 Sciton, Inc.: FINANCIAL OVERVIEW SNAPSHOT\r\n FIGURE 19 Sciton, Inc.: SWOT ANALYSIS\r\n FIGURE 20 Dornier Medtech.: FINANCIAL OVERVIEW SNAPSHOT\r\n FIGURE 21 Dornier Medtech.: SWOT ANALYSIS \r\n FIGURE 22 Merit Medical Systems: FINANCIAL OVERVIEW SNAPSHOT\r\n FIGURE 23 Merit Medical Systems: SWOT ANALYSIS \r\n FIGURE 24 Alma Lasers: FINANCIAL OVERVIEW SNAPSHOT \r\n FIGURE 25 Alma Lasers: SWOT ANALYSIS\r\n FIGURE 26 Biolitec AG: FINANCIAL OVERVIEW SNAPSHOT\r\n FIGURE 27 Biolitec AG: SWOT ANALYSIS \r\n FIGURE 28 Boston Scientific Corporation: FINANCIAL OVERVIEW SNAPSHOT\r\n FIGURE 29 Boston Scientific Corporation: SWOT ANALYSIS

    Market Segmentation

    Varicose Veins Treatment Devices Market Type Outlook (Revenue, USD Billion, 2018 - 2032)

    Endovenous Ablation

    Sclerotherapy

    Surgical Ligation & Stripping

    Varicose Veins Treatment Devices Market End Use Outlook (Revenue, USD Billion, 2018 - 2032)

    Vein Clinics

    Hospitals

    Ambulatory Care Unit

    Varicose Veins Treatment Devices Market Regional Outlook (Revenue, USD Billion, 2018 - 2032)

    North America Outlook (USD Billion, 2018 - 2032)

    Varicose Veins Treatment Devices Market by Type

    Endovenous Ablation

    Sclerotherapy

    Surgical Ligation & Stripping

    Varicose Veins Treatment Devices Market by End Use

    Vein Clinics

    Hospitals

    Ambulatory Care Unit

    US Outlook (USD Billion, 2018 - 2032)

    Varicose Veins Treatment Devices Market by Type

    Endovenous Ablation

    Sclerotherapy

    Surgical Ligation & Stripping

    Varicose Veins Treatment Devices Market by End Use

    Vein Clinics

    Hospitals

    Ambulatory Care Unit

    Canada Outlook (USD Billion, 2018 - 2032)

    Varicose Veins Treatment Devices Market by Type

    Endovenous Ablation

    Sclerotherapy

    Surgical Ligation & Stripping

    Varicose Veins Treatment Devices Market by End Use

    Vein Clinics

    Hospitals

    Ambulatory Care Unit

    Europe Outlook (USD Billion, 2018 - 2032)

    Varicose Veins Treatment Devices Market by Type

    Endovenous Ablation

    Sclerotherapy

    Surgical Ligation & Stripping

    Varicose Veins Treatment Devices Market by End Use

    Vein Clinics

    Hospitals

    Ambulatory Care Unit

    Germany Outlook (USD Billion, 2018 - 2032)

    Varicose Veins Treatment Devices Market by Type

    Endovenous Ablation

    Sclerotherapy

    Surgical Ligation & Stripping

    Varicose Veins Treatment Devices Market by End Use

    Vein Clinics

    Hospitals

    Ambulatory Care Unit

    France Outlook (USD Billion, 2018 - 2032)

    Varicose Veins Treatment Devices Market by Type

    Endovenous Ablation

    Sclerotherapy

    Surgical Ligation & Stripping

    Varicose Veins Treatment Devices Market by End Use

    Vein Clinics

    Hospitals

    Ambulatory Care Unit

    UK Outlook (USD Billion, 2018 - 2032)

    Varicose Veins Treatment Devices Market by Type

    Endovenous Ablation

    Sclerotherapy

    Surgical Ligation & Stripping

    Varicose Veins Treatment Devices Market by End Use

    Vein Clinics

    Hospitals

    Ambulatory Care Unit

    Italy Outlook (USD Billion, 2018 - 2032)

    Varicose Veins Treatment Devices Market by Type

    Endovenous Ablation

    Sclerotherapy

    Surgical Ligation & Stripping

    Varicose Veins Treatment Devices Market by End Use

    Vein Clinics

    Hospitals

    Ambulatory Care Unit

    Spain Outlook (USD Billion, 2018 - 2032)

    Varicose Veins Treatment Devices Market by Type

    Endovenous Ablation

    Sclerotherapy

    Surgical Ligation & Stripping

    Varicose Veins Treatment Devices Market by End Use

    Vein Clinics

    Hospitals

    Ambulatory Care Unit

    Rest Of Europe Outlook (USD Billion, 2018 - 2032)

    Varicose Veins Treatment Devices Market by Type

    Endovenous Ablation

    Sclerotherapy

    Surgical Ligation & Stripping

    Varicose Veins Treatment Devices Market by End Use

    Vein Clinics

    Hospitals

    Ambulatory Care Unit

    Asia-Pacific Outlook (USD Billion, 2018 - 2032)

    Varicose Veins Treatment Devices Market by Type

    Endovenous Ablation

    Sclerotherapy

    Surgical Ligation & Stripping

    Varicose Veins Treatment Devices Market by End Use

    Vein Clinics

    Hospitals

    Ambulatory Care Unit

    China Outlook (USD Billion, 2018 - 2032)

    Varicose Veins Treatment Devices Market by Type

    Endovenous Ablation

    Sclerotherapy

    Surgical Ligation & Stripping

    Varicose Veins Treatment Devices Market by End Use

    Vein Clinics

    Hospitals

    Ambulatory Care Unit

    Japan Outlook (USD Billion, 2018 - 2032)

    Varicose Veins Treatment Devices Market by Type

    Endovenous Ablation

    Sclerotherapy

    Surgical Ligation & Stripping

    Varicose Veins Treatment Devices Market by End Use

    Vein Clinics

    Hospitals

    Ambulatory Care Unit

    India Outlook (USD Billion, 2018 - 2032)

    Varicose Veins Treatment Devices Market by Type

    Endovenous Ablation

    Sclerotherapy

    Surgical Ligation & Stripping

    Varicose Veins Treatment Devices Market by End Use

    Vein Clinics

    Hospitals

    Ambulatory Care Unit

    Australia Outlook (USD Billion, 2018 - 2032)

    Varicose Veins Treatment Devices Market by Type

    Endovenous Ablation

    Sclerotherapy

    Surgical Ligation & Stripping

    Varicose Veins Treatment Devices Market by End Use

    Vein Clinics

    Hospitals

    Ambulatory Care Unit

    Rest of Asia-Pacific Outlook (USD Billion, 2018 - 2032)

    Varicose Veins Treatment Devices Market by Type

    Endovenous Ablation

    Sclerotherapy

    Surgical Ligation & Stripping

    Varicose Veins Treatment Devices Market by End Use

    Vein Clinics

    Hospitals

    Ambulatory Care Unit

    Rest of the World Outlook (USD Billion, 2018 - 2032)

    Varicose Veins Treatment Devices Market by Type

    Endovenous Ablation

    Sclerotherapy

    Surgical Ligation & Stripping

    Varicose Veins Treatment Devices Market by End Use

    Vein Clinics

    Hospitals

    Ambulatory Care Unit

    Middle East Outlook (USD Billion, 2018 - 2032)

    Varicose Veins Treatment Devices Market by Type

    Endovenous Ablation

    Sclerotherapy

    Surgical Ligation & Stripping

    Varicose Veins Treatment Devices Market by End Use

    Vein Clinics

    Hospitals

    Ambulatory Care Unit

    Africa Outlook (USD Billion, 2018 - 2032)

    Varicose Veins Treatment Devices Market by Type

    Endovenous Ablation

    Sclerotherapy

    Surgical Ligation & Stripping

    Varicose Veins Treatment Devices Market by End Use

    Vein Clinics

    Hospitals

    Ambulatory Care Unit

    Latin America Outlook (USD Billion, 2018 - 2032)

    Varicose Veins Treatment Devices Market by Type

    Endovenous Ablation

    Sclerotherapy

    Surgical Ligation & Stripping

    Varicose Veins Treatment Devices Market by End Use

    Vein Clinics

    Hospitals

    Ambulatory Care Unit

    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027